100

breakthroughs in wearable glucose monitoring. Tracks stories on non-invasive sensors and FDA approvals relevant to metabolic health.

Breakthroughs in Wearable Glucose Monitoring

A curated reading list covering investigational non-invasive and minimally invasive sensors, plus recent FDA records for wearable glucose monitors. The investigational prototypes remain preclinical or early-validation technologies and are not FDA-approved for clinical use.[1]

Investigational non-invasive and minimally invasive breakthroughs

Peer-reviewed sources on tear-based smart contact lenses and a self-powered microneedle sensor. The contact-lens work is non-invasive and at feasibility or early-validation stage; the microneedle device is minimally invasive and has reached in vivo prototype testing, without reported clinical approval or commercialization.

nih.gov15 Feb 2026
Yazdani J, Mafatia K, Harun-Or-Rashid M et al.Biosensors & bioelectronics
Recent advances in nanotechnology have enabled the development of nanosensor-embedded, near-field comm...
nih.gov1 Apr 2026
academicpeer-reviewed
Zhanhong Li, Haotian Li, Jingxuan Huang et al.Biosensors & bioelectronics
Authors: Zhanhong Li, Haotian Li, Jingxuan Huang, Zheyuan Fan, Wen Sun, Longzhao Chen | Journal: Biosensors & ...

FDA-authorized or cleared wearable glucose monitors

FDA press and regulatory records covering recent wearable glucose-monitoring decisions, including Biolinq Shine, Dexcom G7 systems, and an over-the-counter CGM cleared for children. Review each record for device classification, intended users, clearance pathway, and decision date.

fda.gov
fda.gov
action based on the device output without consultation with a qualified healthcare professional. FDA concludes...
fda.gov
fda.gov
monitoring (CGM) systems intended to continuously measure the glucose in the interstitial fluid, calculate the...
fda.gov
The U.S. Food and Drug Administration today cleared for marketing the first over-the-counter (OTC) continuous ...